Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,252,854
-$636,853 QoQ
Shares Held
2,712
-35.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#2,052
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $15,619,590 across 5 Drug Manufacturers - General names. LLY ranks #4 (20.8% of the industry book) .
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,252,854 | 2,712 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $3,889,707 | 4,229 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $3,658,211 | 3,404 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $677,544 | 888 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $692,222 | 888 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,200,873 | 1,454 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $1,122,488 | 1,454 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $2,726,037 | 3,077 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $2,785,854 | 3,077 | Shares | Other | 2024-07-26 | |
| 2024-03-31 | $3,204,417 | 4,119 | Shares | Other | 2024-04-15 | |
| 2023-12-31 | $2,401,047 | 4,119 | Shares | Other | 2024-01-16 | |
| 2023-09-30 | $2,212,438 | 4,119 | Shares | Other | 2023-10-12 | |
| 2023-06-30 | $3,058,218 | 6,521 | Shares | Other | 2023-08-18 | |
| 2023-03-31 | $2,239,441 | 6,521 | Shares | Other | 2023-05-25 | |
| 2022-12-31 | $2,385,642 | 6,521 | Shares | Other | 2023-02-01 | |
| No filing history on record for this holder in this stock. | ||||||